| 000 -LEADER |
|---|
| fixed length control field |
00683nam a2200217#a 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
0000003157 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
211117s2020||||xx |||||||||||||| ||und|| |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
0671510576 |
| Qualifying information |
(pbk.) |
| 082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
615.19 WER 1994 |
| 100 ## - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Werth |
| 245 #4 - TITLE STATEMENT |
|---|
| Title |
The billion-dollar molecule : one company's quest for the perfect drug |
| Statement of responsibility, etc. |
/ Barry Werth. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Place of publication, distribution, etc. |
New York |
| Name of publisher, distributor, etc. |
Touchstone |
| Date of publication, distribution, etc. |
1994. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
455p. |
| Other physical details |
ill. |
| Dimensions |
21cm |
| 365 ## - TRADE PRICE |
|---|
| Currency code |
MYR |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc. note |
Includes bibliographical references and index |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Pharmaceutical biotechnology |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Pharmaceutical industry |
| Geographic subdivision |
United States |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Vertex Pharmaceuticals Incorporated |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Koha item type |
Book-GN |
